Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
96 studies found for:    Menstruation Disturbances: Clinical Trials
Show Display Options
Rank Status Study
21 Completed Comparison Between Oral Contraceptive Pills and Calcium Supplements in Treatment of Premenstrual Syndrome
Condition: Premenstrual Syndrome
Interventions: Drug: Yasmin;   Dietary Supplement: Calver;   Drug: Placebo 1;   Drug: Placebo 2
22 Completed Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids
Conditions: Menorrhagia;   Leiomyoma;   Uterine Neoplasms
Interventions: Procedure: uterine artery embolization;   Procedure: hysterectomy
23 Completed
Has Results
Tranexamic Acid (TA) vs Combined Oral Contraceptive (COCP) Pilot Study
Condition: Menorrhagia
Interventions: Drug: Oral tranexamic acid;   Drug: Oral Contraceptive Pills
24 Terminated Efficacy and Safety of 20 mg (2 Tablets of 10mg)VAC BNO 1095 FCT on Cyclic Mastodynia and PMS
Conditions: Premenstrual Syndrome;   Mastodynia
Interventions: Drug: 20mg VAC BNO 1095 FCT;   Drug: Placebo
25 Completed Treatment of Primary Menstrual Pain With Kanion Capsule
Condition: Primary Dysmenorrhea
Intervention: Drug: Kanion Capsule
26 Terminated
Has Results
The Luveris In Vitro Fertilization Trial
Conditions: Infertility;   Hypothalamic Amenorrhea;   Hyperprolactinemia
Interventions: Drug: Luveris fixed dose;   Drug: Luveris increasing dose
27 Unknown  Multi-center Clinical Trials of Sanjie Analgesic Capsule in Treating Endometriosis
Condition: Dysmenorrhea
Interventions: Drug: Sanjie analgesic capsule;   Drug: placebo
28 Recruiting A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
Conditions: Contraception;   Menorrhagia
Interventions: Device: ESS305 (Essure, BAY1454032);   Procedure: NovaSure
29 Active, not recruiting Oral Micronized Progesterone Effects on Perimenopausal Menstrual Flow
Conditions: Perimenopause;   Menstrual Cramps
Interventions: Drug: Oral Micronized Progesterone;   Drug: Placebo
30 Active, not recruiting Safety & Effectiveness Study of AEGEA Vapor System to Treat Excessive Uterine Bleeding
Condition: Menorrhagia
Intervention: Device: AEGEA Vapor System(TM)
31 Recruiting Copper IUD Treatment Observation Study
Condition: Menorrhagia
Interventions: Drug: Naproxen;   Drug: Placebo
32 Enrolling by invitation A Trial for Evaluation of Clinical Efficacy and Safety of Healing Stone Navel Belt in Patients With Primary Dysmenorrhea
Condition: Primary Dysmenorrhea
Intervention: Device: Healingstone navel belt
33 Recruiting Danshen-Jiang-Fu Granule Prepared by Danshen From Different Producing Areas for Primary Dysmenorrhea
Conditions: Primary Dysmenorrhea;   Traditional Chinese Medicine
Interventions: Drug: Shandong Danshen-Jiang-Fu Granule;   Drug: Sichuan Danshen-Jiang-Fu Granule
34 Recruiting Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea
Condition: Menorrhagia, Dysmenorrhea
Intervention: Drug: Mirena (Levonorgestrel IUS, BAY86-5028)
35 Unknown  Treatment of Menstrual Migraine With Sequential, Transdermal, 17-Beta-Estradiol. A Double-Blind, Randomised, Cross-Over Trial.
Condition: Migraine
Intervention: Drug: 17-beta-estradiol (drug)
36 Completed Effectiveness of Vitamin D in Primary Dysmenorrhoea
Condition: Primary Dysmenorrhoea
Interventions: Dietary Supplement: Vitamin D;   Dietary Supplement: Vitamin E;   Drug: Ibuprofen
37 Completed
Has Results
Medical Therapy Versus Radiofrequency Endometrial Ablation in the Initial Treatment of Menorrhagia
Condition: Menorrhagia
Interventions: Drug: Estradiol 30mcg / Levonorgestrel 150mcg monophasic oral contraceptive pills;   Drug: Naproxen sodium pills;   Device: NovaSure® Radiofrequency Endometrial Ablation
38 Completed
Has Results
Lysteda Pediatric Research Equity Act (PREA) Pharmacokinetic Study in Adolescent Females With Heavy Menstrual Bleeding
Condition: Menorrhagia
Intervention: Drug: tranexamic acid
39 Not yet recruiting Minimize Menorrhagia in Women With Type 1 Von Willebrand Disease
Condition: Type 1 Von Willebrand Disease
Interventions: Drug: recombinant von Willebrand factor;   Drug: tranexamic acid
40 Recruiting Oral Tranexamic Acid Versus Diosmin for Treatment of Menorrhagia in Women Using Copper IUD
Condition: Menorrhagia
Interventions: Drug: Tranexamic Acid;   Drug: Diosmin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.